{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:06:50Z","timestamp":1775340410901,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T00:00:00Z","timestamp":1344038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00270-012-0458-1","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T17:19:44Z","timestamp":1344014384000},"page":"433-439","source":"Crossref","is-referenced-by-count":28,"title":["Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies"],"prefix":"10.1007","volume":"36","author":[{"given":"Valentina","family":"Bova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Miraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Maruzzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Battista","family":"Vizzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,4]]},"reference":[{"issue":"11","key":"458_CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693\u2013699","journal-title":"N Engl J Med"},{"issue":"5","key":"458_CR2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42(5):1208\u20131236","journal-title":"Hepatology"},{"issue":"9399","key":"458_CR3","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907\u20131917","journal-title":"Lancet"},{"key":"458_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429\u2013442","journal-title":"Hepatology"},{"key":"458_CR5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/bjs.4361","volume":"90","author":"G Sen","year":"2003","unstructured":"Sen G, Rai R, Manas DM (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90:1022","journal-title":"Br J Surg"},{"key":"458_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2006-947295","volume":"26","author":"FY Yao","year":"2006","unstructured":"Yao FY (2006) Expanding criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation. Semin Liver Dis 26:239\u2013247","journal-title":"Semin Liver Dis"},{"issue":"6","key":"458_CR7","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","volume":"33","author":"FY Yao","year":"2001","unstructured":"Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6):1394\u20131403","journal-title":"Hepatology"},{"key":"458_CR8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","volume":"48","author":"FY Yao","year":"2008","unstructured":"Yao FY, Kerlan RK Jr, Hirose R et al (2008) Excellent outcome following downstaging of HCC prior to liver transplantation: an intention-to-treat analysis. Hepatology 48:819\u2013827","journal-title":"Hepatology"},{"key":"458_CR9","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","volume":"8","author":"M Ravaioli","year":"2008","unstructured":"Ravaioli M, Grazi GL, Piscaglia F et al (2008) Liver transplantation for HCC: results of downstaging in patients initially outside the Milan selection criteria. Am J Transplant 8:2547\u20132557","journal-title":"Am J Transplant"},{"key":"458_CR10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/jlts.2003.50106","volume":"9","author":"IW Graziadei","year":"2003","unstructured":"Graziadei IW, Sandmueller H, Waldenberger P et al (2003) Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9:557\u2013563","journal-title":"Liver Transpl"},{"key":"458_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.21994","volume":"16","author":"O Barakat","year":"2010","unstructured":"Barakat O, Wood PR, Ozaki CF et al (2010) Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Liver Transpl 16:289\u2013299","journal-title":"Liver Transpl"},{"key":"458_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360","journal-title":"Semin Liver Dis"},{"key":"458_CR13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020\u20131022","journal-title":"Hepatology"},{"key":"458_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet J, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35\u201343","journal-title":"Lancet Oncol"},{"issue":"7 suppl","key":"458_CR15","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.jvir.2009.04.033","volume":"20","author":"DB Brown","year":"2009","unstructured":"Brown DB, Cardella JF, Sacks D et al (2009) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 20(7 suppl):S219\u2013S226","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"458_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/bjs.7561","volume":"98","author":"AN Gordon-Weeks","year":"2011","unstructured":"Gordon-Weeks AN, Snaith A, Petrinic T et al (2011) Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. Br J Surg 98(9):1201\u20131208","journal-title":"Br J Surg"},{"issue":"1","key":"458_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"458_CR18","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","volume":"56","author":"M Burrel","year":"2012","unstructured":"Burrel M, Reig M, Forner A et al (2012) Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using DC beads. Implications for clinical practice and trial design. J Hepatol 56(6):1330\u20131335","journal-title":"J Hepatol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0458-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-012-0458-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-012-0458-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T08:21:49Z","timestamp":1594542109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-012-0458-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1007\/s00270-012-0458-1","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,4]]}}}